If you are looking into stocks this morning then it could be a good move to consider taking a look at the Marizyme Inc (OTCMKTS:MRZM) stock. The stock was on the radars of investors this past Friday and ended the day with gains of as much as 5% as a consequence.
On Thursday, MRZM stock ended higher by 4.73% to $1.77 with 100 shares, compared to its average volume of 420 shares. The stock has moved within a range of $1.7700 – 1.7700 after opening trade at $1.77.
Announces the Closing of My Health Logic Acquisition Along With Initial Financing
The rally in the stock could be related to the announcement made by the company last Thursday with regards to the closing of the acquisition of the company My Health Logic, which is a subsidiary company of Health Logic Interactive Inc.
In addition to the announcement regarding the acquisition, Marizyme also announced that it had also provided concurrent financing. It was announced that the point of care device and tech platform from My Health Logic are going to help Marizyme in further strengthening is life science technology pipeline.
It now remains to be seen if the stock can manage to stay in focus among investors this week. It should be noted that the healthcare device industry has grown considerably due to the coronavirus pandemic since there is significant demand for home based healthcare options among investors. It could be a good move to add Marizyme to your watch lists.
MRZM stock is trading above the 20-Day and 50-Day Moving averages of $1.52 and $1.44. Moreover, the stock is trading is the overbought zone with RSI stands at 78. Key pivot point is $1.77.